Provider and Organizational Factors Impacting Routine Cancer Screening Among Older Medicaid Enrollees
- PMID: 40878219
- DOI: 10.1111/1475-6773.70030
Provider and Organizational Factors Impacting Routine Cancer Screening Among Older Medicaid Enrollees
Abstract
Objective: To analyze the conditional association between provider and organizational factors and routine cancer screening for older Medicaid enrollees before and during the COVID-19 pandemic.
Study setting and design: This study analyzed pre-pandemic (2018/2019; n = 110,882) and pandemic (2020/2021; n = 107,451) cohorts of New Jersey (NJ) Medicaid enrollees aged 50-75. Using linear probability models, we evaluated how provider and organizational characteristics, including interactions with pandemic years, influenced screening for breast, cervical, colorectal, and lung cancers. Models controlled for enrollees' demographic and clinical characteristics and geographic factors.
Data sources and analytic sample: Claims data from the 2016-2021 NJ Medicaid Management Information System were linked to Medicare Provider and Specialty files. The sample included Medicaid enrollees with an assigned primary care provider and no prior cancer diagnosis.
Principal findings: Higher patient panel sizes were consistently associated with increased screening for breast (20.4%, 95% confidence interval (CI): 13.9%-26.8%), cervical (24.1%, 95% CI: 16.6%-31.5%), and lung cancer (63.1%; 95% CI: 17.4%-108.6%) during the pandemic. Obstetrician-gynecologist providers were linked to higher screening rates for breast (50.6%, 95% CI: 41.6%-59.5%) and cervical cancers (70.5%, 95% CI: 52.3%-88.9%), even during the pandemic. Female providers improved screening rates for breast (7.6%, 95% CI: 2.8%-12.3%), cervical (3.8%, 95% CI: 0.10%-7.5%), and colorectal cancer (5.8%, 95% CI: -2.7%-14.4%) among female enrollees. Provider age was unrelated to breast, cervical, or colorectal screening; however, in 2021, lung cancer screening was 23% lower for patients of clinicians aged 62 and above.
Conclusions: Large group practices effectively maintained breast and cervical cancer screening during the pandemic while exhibiting mixed results for colorectal and lung cancers. Provider characteristics such as gender and specialty also significantly impacted screening rates. Supporting large practices and addressing barriers in smaller practices are key to improving cancer prevention, especially during crises.
Keywords: access/demand/utilization of services; aging/elderly/geriatrics; health care organizations and systems; health promotion/prevention/screening; medicaid.
© 2025 The Author(s). Health Services Research published by Wiley Periodicals LLC.
References
-
- R. C. Chen, K. Haynes, S. Du, J. Barron, and A. J. Katz, “Association of Cancer Screening Deficit in the United States With the COVID‐19 Pandemic,” JAMA Oncology 7, no. 6 (2021): 878–884, https://doi.org/10.1001/jamaoncol.2021.0884.
-
- D. Patt, L. Gordan, M. Diaz, et al., “Impact of COVID‐19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors,” JCO Clinical Cancer Informatics 4 (2020): 1059–1071, https://doi.org/10.1200/CCI.20.00134.
-
- I. Alkatout, M. Biebl, Z. Momenimovahed, et al., “Has COVID‐19 Affected Cancer Screening Programs? A Systematic Review,” Frontiers in Oncology 11 (2021): 675038, https://doi.org/10.3389/fonc.2021.675038.
-
- M. J. Miller, L. Xu, J. Qin, et al., “Impact of COVID‐19 on Cervical Cancer Screening Rates Among Women Aged 21–65 Years in a Large Integrated Health Care System—Southern California, January 1–September 30, 2019, and January 1–September 30, 2020,” Morbidity and Mortality Weekly Report 70, no. 4 (2021): 109–113, https://doi.org/10.15585/mmwr.mm7004a1.
-
- K. R. Yabroff, X. C. Wu, S. Negoita, et al., “Association of the COVID‐19 Pandemic With Patterns of Statewide Cancer Services,” Journal of the National Cancer Institute 114 (2022): 907–909, https://doi.org/10.1093/jnci/djab122.
Grants and funding
LinkOut - more resources
Full Text Sources